Icahn School of Medicine at Mount Sinai | ||
City: New York | State: NY | |
Links:
Updates: This institution's COI policies were evaluated on Apr-14-2014. This institution has indicated their policies have not changed since they were evaluated for 2014 Scorecard. |
Gifts | Gifts from industry are prohibited with the exception of educational items meant primarily for patient use (such as patient-friendly booklets describing organ systems). Institutional gifts from donors are separate and should be directed to the Development [Domain Location: Policy 1, page 5; Policy 4; page 3] |
|
Meals | Food and beverages, or subsidies for food and beverages, from industry is prohibited for both on and off-site activities. [Domain Location: Policy 4, page 4] |
|
Industry-funded promotional speaking relationships (not ACCME-accredited) | While promotional speaking is strongly discouraged, the policy is not restrictive enough to qualify as a model policy on speaker's bureaus. Paid speaking engagements are subject to approval. The policy lays out a list of questions that speakers should con [Domain Location: Policy 4, pages 6-7] |
|
Industry-support of ACCME-accredited CME | ACCME accreditation is required. [Domain Location: Policy 4, page 4-5] |
|
Attendance of industry-sponsored promotional events | Even though the policy does not prohibit attendance, employees and trainees are encouraged to attend off-campus events sponsored by industry only when CME-credit is offered, or those events with 'legitimate educational value'. Moreover, it does not allow [Domain Location: Policy 4, page 6] |
|
Industry-supported scholarships and awards | Scholarship/awards to attend events or trainees is allowed; however, funds must go through a general departmental education fund with assigned criteria to select recipients. Moreover, vendor support for trainee education must be in the form of educational [Domain Location: Policy 4, pgs. 5, 7] |
|
Ghostwriting and honorary authorships | Ghostwriting is strictly prohibited and an author's role in content and contributions must be verifiable. [Domain Location: Policy 4, page 8] |
|
Consulting and advising relationships | Consulting by full-time faculty must be reviewed and approved by department chair. Remuneration must be fair market value. [Domain Location: Policy 3, pages 1-2; Policy 4, page 13] |
|
Access of pharmaceutical sales representatives | Pharmaceutical sales representatives are allowed access to health care staff as long as they have an appointment and meet in non-patient care areas. [Domain Location: Policy 4, page 5; Policy 2] |
|
Access of medical device representatives | Access by medical device representatives to patient care areas is permitted by appointment to train physicians, researchers and others in device use or new technologies. These visits specify talking about and demonstrating new products, and states that pr [Domain Location: Policy 4, page 5; Policy 2; page 5] |
|
Conflict of interest disclosure | Internal disclosure is required annually. Faculty must disclose any business conflict of interest at the time that conflict arises. Research faculty are required to submit annual disclosure forms to institution (per federal regulations) and externally whe [Domain Location: Policy 1, pages 5-8; Policy 6, page 2] |
|
COI curriculum | Although the policy does not state anything related to curriculum, the institution noted during its policy submission a COI curriculum is required for all medical students. The information is presented through a syllabus, slides and learning objectives. F [Domain Location: As identified in submitted materials, but not expressly stated in the policy.] |
|
Extension of COI policies to community affiliates | This policy applies to all employees of the institution, whether full/part-time or volunteer faculty, and it applies to them regardless of the site where they are working. [Domain Location: Policy 1, page 2] |
|
Enforcement and Sanctions of Policies | There is an oversight authority for policies and sanctions in place for non compliance. [Domain Location: Policy 1, pages 6-9] |
Model policy | |
Good progress toward model policy | |
No policy, or policy unlikely to have a substantial effect on behavior |